TransMedics Group, Inc. Cost of Revenue
TransMedics Group, Inc. (TMDX) reported Cost of Revenue of $76.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-04
- TransMedics Group, Inc. cost of revenue for the quarter ending 2026-06-30 was $76.75M, a 26.27% increase year-over-year.
- TransMedics Group, Inc. cost of revenue for the quarter ending 2026-03-31 was $72.77M, a 31.57% increase year-over-year.
- TransMedics Group, Inc. cost of revenue for the quarter ending 2025-12-31 was $67.35M, a 35.76% increase year-over-year.
- TransMedics Group, Inc. cost of revenue for the quarter ending 2025-09-30 was $59.25M, a 23.65% increase year-over-year.
- TransMedics Group, Inc. cost of revenue for fiscal 2025 was $242.69M, a 35.23% increase from fiscal 2024.
- TransMedics Group, Inc. cost of revenue for fiscal 2024 was $179.46M, a 105.03% increase from fiscal 2023.
- TransMedics Group, Inc. cost of revenue for fiscal 2023 was $87.53M, a 210.53% increase from fiscal 2022.
- TransMedics Group, Inc. cost of revenue for fiscal 2022 was $28.19M, a 209.65% increase from fiscal 2021.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $76.75M 10-Q · filed 2026-08-04 | $149.52M 10-Q · filed 2026-08-04 | $216.87M derived: sum of 3 quarters · filed 2026-08-04 | $276.12M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $72.77M 10-Q · filed 2026-05-05 | $140.12M derived: sum of 2 quarters · filed 2026-05-05 | $199.37M derived: sum of 3 quarters · filed 2026-05-05 | $260.15M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $67.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $126.60M derived: sum of 2 quarters · filed 2026-02-24 | $187.38M derived: sum of 3 quarters · filed 2026-08-04 | $242.69M 10-K · filed 2026-02-24 |
| 2025-09-30 | $59.25M 10-Q · filed 2025-10-29 | $120.03M derived: sum of 2 quarters · filed 2026-08-04 | $175.34M 10-Q · filed 2025-10-29 | $224.95M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $60.78M 10-Q · filed 2026-08-04 | $116.09M 10-Q · filed 2026-08-04 | $165.70M derived: sum of 3 quarters · filed 2026-08-04 | $213.62M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $55.31M 10-Q · filed 2026-05-05 | $104.92M derived: sum of 2 quarters · filed 2026-05-05 | $152.84M derived: sum of 3 quarters · filed 2026-05-05 | $197.88M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $49.61M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $97.53M derived: sum of 2 quarters · filed 2026-02-24 | $142.57M derived: sum of 3 quarters · filed 2026-02-24 | $179.46M 10-K · filed 2026-02-24 |
| 2024-09-30 | $47.92M 10-Q · filed 2025-10-29 | $92.96M derived: sum of 2 quarters · filed 2025-10-29 | $129.85M 10-Q · filed 2025-10-29 | $163.10M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-06-30 | $45.04M 10-Q · filed 2025-07-30 | $81.93M 10-Q · filed 2025-07-30 | $115.18M derived: sum of 3 quarters · filed 2026-02-24 | $140.95M derived: sum of 4 quarters · filed 2026-02-24 |
| 2024-03-31 | $36.89M 10-Q · filed 2025-05-08 | $70.14M derived: sum of 2 quarters · filed 2026-02-24 | $95.91M derived: sum of 3 quarters · filed 2026-02-24 | $111.63M derived: sum of 4 quarters · filed 2026-02-24 |
| 2023-12-31 | $33.25M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $59.02M derived: sum of 2 quarters · filed 2026-02-24 | $74.74M derived: sum of 3 quarters · filed 2026-02-24 | $87.53M 10-K · filed 2026-02-24 |
| 2023-09-30 | $25.77M 10-Q · filed 2024-10-29 | $41.49M derived: sum of 2 quarters · filed 2024-10-29 | $54.28M 10-Q · filed 2024-10-29 | $64.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $15.72M 10-Q · filed 2024-08-01 | $28.51M 10-Q · filed 2024-08-01 | $39.18M derived: sum of 3 quarters · filed 2025-02-27 | $46.75M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $12.79M 10-Q · filed 2024-05-02 | $23.46M derived: sum of 2 quarters · filed 2025-02-27 | $31.03M derived: sum of 3 quarters · filed 2025-02-27 | $37.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $10.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $18.24M derived: sum of 2 quarters · filed 2025-02-27 | $24.41M derived: sum of 3 quarters · filed 2025-02-27 | $28.19M 10-K · filed 2025-02-27 |
| 2022-09-30 | $7.57M 10-Q · filed 2023-11-08 | $13.74M derived: sum of 2 quarters · filed 2023-11-08 | $17.52M 10-Q · filed 2023-11-08 | $20.20M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $6.17M 10-Q · filed 2023-08-04 | $9.95M 10-Q · filed 2023-08-04 | $12.63M derived: sum of 3 quarters · filed 2024-02-27 | $14.23M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $3.78M 10-Q · filed 2023-05-04 | $6.46M derived: sum of 2 quarters · filed 2024-02-27 | $8.05M derived: sum of 3 quarters · filed 2024-02-27 | $10.64M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $4.28M derived: sum of 2 quarters · filed 2024-02-27 | $6.86M derived: sum of 3 quarters · filed 2024-02-27 | $9.10M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.60M 10-Q · filed 2022-11-04 | $4.18M derived: sum of 2 quarters · filed 2022-11-04 | $6.42M 10-Q · filed 2022-11-04 | $9.22M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-06-30 | $2.58M 10-Q · filed 2022-08-03 | $4.82M 10-Q · filed 2022-08-03 | $7.62M derived: sum of 3 quarters · filed 2023-02-27 | $9.68M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-03-31 | $2.24M 10-Q · filed 2022-05-05 | $5.04M derived: sum of 2 quarters · filed 2023-02-27 | $7.09M derived: sum of 3 quarters · filed 2023-02-27 | $8.58M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $2.80M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $4.85M derived: sum of 2 quarters · filed 2023-02-27 | $6.33M derived: sum of 3 quarters · filed 2023-02-27 | $9.00M 10-K · filed 2021-03-11 |
| 2020-09-30 | $2.05M 10-Q · filed 2021-11-09 | $3.54M derived: sum of 2 quarters · filed 2021-11-09 | $6.21M 10-Q · filed 2021-11-09 | $8.52M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $1.48M 10-Q · filed 2021-08-06 | $4.15M 10-Q · filed 2021-08-06 | $6.47M derived: sum of 3 quarters · filed 2021-08-06 | $9.46M derived: sum of 4 quarters · filed 2021-08-06 |
| 2020-03-31 | $2.67M 10-Q · filed 2021-05-07 | $4.99M derived: sum of 2 quarters · filed 2021-05-07 | $7.97M derived: sum of 3 quarters · filed 2021-05-07 | $10.31M derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-28 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $5.30M derived: sum of 2 quarters · filed 2021-03-11 | $7.64M derived: sum of 3 quarters · filed 2021-03-11 | $9.74M 10-K · filed 2021-03-11 |
| 2019-09-28 | $2.99M 10-Q · filed 2020-11-06 | $5.32M derived: sum of 2 quarters · filed 2020-11-06 | $7.42M 10-Q · filed 2019-11-08 | |
| 2019-06-29 | $2.33M 10-Q · filed 2020-08-07 | $4.44M 10-Q · filed 2020-08-07 | ||
| 2019-03-30 | $2.10M 10-Q · filed 2020-05-06 | |||
| 2018-12-29 | $7.28M 10-K · filed 2020-03-17 | |||
| 2018-09-29 | $1.91M 10-Q · filed 2019-11-08 | $3.64M derived: sum of 2 quarters · filed 2019-11-08 | $5.24M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $1.74M 10-Q · filed 2019-08-08 | $3.33M 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $1.59M 10-Q · filed 2019-06-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |